
Soitec Reports Second Quarter Revenue And Half-Year Results Of Fiscal Year 2027 Strong AI-Driven Photonics-SOI Momentum And POI Drive H1’27 Revenue Growth, Gross Margin Improvement And Strong Cash Generation In line with updated guidance, Soitec Q2’27 revenue grew 50% at constant currency and scope compared with Q2’26, to €204m (+46% year-on-year on a reported basis), driven by strong Photonics-SOI and POI performance. Photonics-SOI Q2’27 revenue reached approximately $75m. H1’27 revenue amounte
Please find below Aedifica’s interim financial report for the 3 rd quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Following a legal merger by absorption on 1 July 2026, Aedifica owns 100% of the shares in Cofinimmo, resulting in the delisting of Cofinimmo from Euronext A new Board of Directors and Executive Committee were appointed earlier this year, and the integration process is well on track With legal merger completed, expected synergies will accelerate further
newsStrong sales growth and improved year-on-year results in the first nine months, despite lower EBITDA Sales for 9M 2026: €392.7m, up 13% from 9M 2025 Net margin for 9M 2026: €34.4m, up from €34.2m in 9M 2025 EBITDA for 9M 2026 was €12.6m, compared with €14m in 9M 2025 12-month EBITDA amounted to €21.4m Normalised profit before tax for 9M 2026: €4.2m, up from €4.1m in 9M 2025 Net profit for 9M 2026: €3.1m, compared with €2.5m for 9M 2025 Basic earnings per share (EPS) for 9M 2026 were 0.1034 EUR c

Soitec Reports Second Quarter Revenue And Half-Year Results Of Fiscal Year 2027 Strong AI-Driven Photonics-SOI Momentum And POI Drive H1’27 Revenue Growth, Gross Margin Improvement And Strong Cash Generation In line with updated guidance, Soitec Q2’27 revenue grew 50% at constant currency and scope compared with Q2’26, to €204m (+46% year-on-year on a reported basis), driven by strong Photonics-SOI and POI performance. Photonics-SOI Q2’27 revenue reached approximately $75m. H1’27 revenue amounte
Please find below Aedifica’s interim financial report for the 3 rd quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Following a legal merger by absorption on 1 July 2026, Aedifica owns 100% of the shares in Cofinimmo, resulting in the delisting of Cofinimmo from Euronext A new Board of Directors and Executive Committee were appointed earlier this year, and the integration process is well on track With legal merger completed, expected synergies will accelerate further
newsQuarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its transition to a technology infrastructure business MATAWAN, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. ( NYSE American: APUS ) (“Apimeds” or the “Company”), today reported financial results for the third quarter ended September 30, 2026, as filed in its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. Third Quarter 2026 Highli

Quarterly revenue of $2.89 million and operating income of $2.0 million as the company completes its transition to a technology infrastructure business MATAWAN, N.J., Nov. 18, 2026 (GLOBE NEWSWIRE) -- via IBN – Apimeds Pharmaceuticals US, Inc. ( NYSE American: APUS ) (“Apimeds” or the “Company”), today reported financial results for the third quarter ended September 30, 2026, as filed in its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. Third Quarter 2026 Highli
COPENHAGEN, Denmark, November 18, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will provide a strategy and business update and report its third quarter 2026 financial results on Thursday November 19, 2026, before opening of the Nasdaq CM. Evaxion’s executive management will host a conference call and webcast at 8.30am ET/14.30 CET the same day, presenting the strategy and business upd
newsATHENS, Greece, Nov. 18, 2026 (GLOBE NEWSWIRE) -- C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing drybulk and tanker seaborne transportation services, announced today its unaudited financial and operating results for the third quarter and nine months ended September 30, 2026. OPERATIONAL AND FINANCIAL HIGHLIGHTS Our handysize dry bulk carriers are on time charters of short-term durations, producing steady cash flows, while our tankers operate mainly in the spot market.

The nasal spray market is projected to register a CAGR of 12.68% from 2027 to 2032, with Asia-Pacific emerging as the fastest-growing regional market. Hyderabad, India, Nov. 18, 2026 (GLOBE NEWSWIRE) -- The global nasal spray market is expected to grow from USD 28.28 billion in 2026 to USD 31.87 billion in 2027 and reach USD 57.9 billion by 2032 , registering a CAGR of 12.68% during the forecast period (2027–2032) . Rising prevalence of allergic rhinitis, growing preference for self-medication,
Soitec Reports Second Quarter Revenue And Half-Year Results Of Fiscal Year 2027 Strong AI-Driven Photonics-SOI Momentum And POI Drive H1’27 Revenue Growth, Gross Margin Improvement And Strong Cash Generation In line with updated guidance, Soitec Q2’27 revenue grew 50% at constant currency and scope compared with Q2’26, to €204m (+46% year-on-year on a reported basis), driven by strong Photonics-SOI and POI performance. Photonics-SOI Q2’27 revenue reached approximately $75m. H1’27 revenue amounte
newsNearly 190,000 passengers booked worldwide over twelve months as global expansion, repeat travel and forward reservations strengthen inCruises' role as a cruise distribution partner GUAYNABO, Puerto Rico, Nov. 18, 2026 (GLOBE NEWSWIRE) -- inCruises, one of the world's largest subscription-based travel clubs, today announced strong global cruise booking growth, expanding international reach and significant increases in forward reservations booked 270 or more days in advance. During the twelve mon

PRESS RELEASE REGULATED INFORMATION Brussels, 18 November 2026, 5:55 PM NEXTENSA STRENGTHENS ITS FINANCIAL POSITION AND COMPLETES SIGNIFICANT REAL ESTATE TRANSACTIONS IN Q3 2026 Brussels, 18 November 2026 – Nextensa made further progress in the third quarter of 2026, with the sale of The Stairs in Luxembourg and the agreement with the EIB Group for Treemont in Brussels. Following the end of the quarter, further commercial successes included the sale of the Mercator-High5! Office building and the
Please find below Aedifica’s interim financial report for the 3 rd quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Following a legal merger by absorption on 1 July 2026, Aedifica owns 100% of the shares in Cofinimmo, resulting in the delisting of Cofinimmo from Euronext A new Board of Directors and Executive Committee were appointed earlier this year, and the integration process is well on track With legal merger completed, expected synergies will accelerate further
newsBayport Management Ltd Unaudited Financial Statements September 2026
Growth is being redefined. Expanding revenue remains important, but businesses are placing greater emphasis on profitability, cash discipline, operational efficiency, customer retention and resilience. This edition explores the changing growth playbook and the foundations required for sustainable expansion. From technology and process design to capital allocation and market reach, it examines how businesses can pursue ambition without allowing complexity, costs or uncontrolled expansion to weaken the enterprise.
For years, growth was often discussed primarily in terms of size, speed and market share. The conversation is becoming more balanced. Strong businesses also need healthy economics, efficient operations and the ability to withstand uncertainty. This edition looks at growth through that wider lens and considers how organizations can expand with greater discipline, clarity and long-term purpose in practice.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.